We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
51
Rigel Pharmaceuticals
RIGL
$744M
$27.3M 0.41%
1,516,000
+364,000
+32% +$7.39M
PRTA icon
52
Prothena Corp
PRTA
$443M
$27.2M 0.41%
2,196,000
-40,000
-2% -$566K
PFGC icon
53
Performance Food Group
PFGC
$18B
$25.6M 0.38%
325,691
+5,547
+2% +$463K
SHAK icon
54
Shake Shack
SHAK
$2.88B
$25.1M 0.38%
285,021
+99,525
+54% +$10.8M
GEHC icon
55
GE HealthCare
GEHC
$31.6B
$24.5M 0.37%
303,060
-91,251
-23% -$7.84M
WDAY icon
56
Workday
WDAY
$41.2B
$24.3M 0.36%
103,886
-10,820
-9% -$2.76M
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$122B
$24.2M 0.36%
50,000
-174,016
-78% -$81.1M
DDOG icon
58
Datadog
DDOG
$85.6B
$23.8M 0.36%
240,000
+48,213
+25% +$6.08M
BCYC
59
Bicycle Therapeutics
BCYC
$278M
$22.7M 0.34%
2,672,000
+476,000
+22% +$5.61M
IRON icon
60
Disc Medicine
IRON
$3.03B
$21.6M 0.32%
436,000
+80,000
+22% +$4.45M
NOMD icon
61
Nomad Foods
NOMD
$1.65B
$20.1M 0.3%
1,025,064
-649,122
-39% -$11.9M
IRWD icon
62
Ironwood Pharmaceuticals
IRWD
$709M
$20.1M 0.3%
13,700,000
+4,232,000
+45% +$10.1M
HELE icon
63
Helen of Troy
HELE
$683M
$19.8M 0.3%
+371,000
New +$21.4M
EL icon
64
Estee Lauder
EL
$31.7B
$19.7M 0.3%
+299,157
New +$21.6M
ANGO icon
65
AngioDynamics
ANGO
$632M
$19.7M 0.29%
2,094,000
+1,222,000
+140% +$12.8M
CHDN icon
66
Churchill Downs
CHDN
$6.12B
$19.5M 0.29%
175,308
-283
-0.2% -$33.8K
TRVI icon
67
Trevi Therapeutics
TRVI
$2.63B
$18.8M 0.28%
+2,988,000
New +$14.3M
PATH icon
68
UiPath
PATH
$7.12B
$18.5M 0.28%
1,799,689
+1,237,782
+220% +$15.9M
VYGR icon
69
Voyager Therapeutics
VYGR
$189M
$18.4M 0.28%
5,436,000
+40,000
+0.7% +$187K
WH icon
70
Wyndham Hotels & Resorts
WH
$5.65B
$18.1M 0.27%
199,983
-24,646
-11% -$2.5M
SN icon
71
SharkNinja
SN
$26.1B
$17.5M 0.26%
210,359
+72,538
+53% +$7.38M
ICLR icon
72
Icon
ICLR
$12.4B
$17.5M 0.26%
100,052
-318,060
-76% -$61.7M
UBER icon
73
Uber
UBER
$141B
$17.2M 0.26%
235,747
-99,788
-30% -$7.19M
AUTL
74
Autolus Therapeutics
AUTL
$535M
$17.1M 0.26%
11,000,000
+1,800,000
+20% +$3.65M
RH icon
75
RH
RH
$3.65B
$17M 0.25%
72,566
+52,625
+264% +$18.2M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.